Boehringer Ingelheim partners with Ribo to develop new treatments for people with liver diseases Ruchika Sharma3 Jan 2024 1:53 PM ISTIngelheim: Suzhou Ribo Life Science Co., Ltd. and Ribocure Pharmaceuticals AB (Ribo) have announced a collaboration with Boehringer Ingelheim to...
Gastric Bypass improves Metabolic Dysfunction-Associated Fatty Liver Disease in Low-BMI Patients Dr.Niharika Harsha B11 Oct 2022 9:30 AM ISTA new study found that Roux-en-Y gastric bypass therapy showed good results in patients having low-body mass index with insulin-treated type 2...
NAFLD among children and young adults associated with increased long-term mortality MD Editorial Team22 Nov 2021 9:00 AM ISTIn a new study conducted by Tracey G. Simon and colleagues, it was noted that Swedish children and young adults with biopsy-confirmed non-alcoholic...
